Capture patient data direct from source with Reportum
August 12, 2024
A complete picture of drug safety cannot be created if only part of the available data is captured, however the current adverse event capture process
A complete picture of drug safety cannot be created if only part of the available data is captured, however the current adverse event capture process
Through the input of industry leader members of the PV Insights Network, Qinecsa focuses on providing solutions to the safety challenges facing small pharmaceutical and
A top 10 pharma company faced challenges in standardizing safety surveillance across Pharma, Vaccine, and Consumer Health units, including consolidating signal teams, facilitating a divestment,
In her latest article for IPI, Qinecsa President, Humaira Qureshi discussed the practical challenges of integrating medical devices into pharmacovigilance portfolios, the obligations of device
In her latest article for IPI, Qinecsa President, Humaira Qureshi, addresses the practical challenges of integrating medical devices into pharmacovigilance portfolios. She explores the obligations
A head of our first exhibition at the DIA Global Annual Meeting, taking place in San Diego from June 16th-20th, Qinecsa spoke with Outsourcing-Pharma about our
Following her attendance at DIA Europe 2024, Humaira Qureshi, President of Qinecsa Solutions, spoke with PharmaPhorum about the transforming pharmacovigilance landscape, the potential barriers and
We are thrilled to announce that Humaira Qureshi, President of Qinecsa, will be a keynote speaker at the upcoming Insife Annual Convention 2024. The event
Ahead of exhibiting at the 2024 DIA Global Annual Meeting, Qinecsa spoke with industry leading journal Outsourcing Pharma about the company’s latest breakthrough in clinical
Webinar: Vigilance Medical Device Guidance – Part 2 Post-Marketing Safety Surveillance of Medical Devices and DDC Products, EU and USA Join us for Part 2
2 Leman Street,
London, E1W 9US
United Kingdom
Company number: 13916274
